Literature DB >> 11142635

Involvement of NMDA receptors within the amygdala in short- versus long-term memory for fear conditioning as assessed with fear-potentiated startle.

D L Walker1, M Davis.   

Abstract

Pretraining intra-amygdala infusions of the NMDA receptor antagonist. D,L-AP5, block fear-potentiated startle in rats tested 24+ hr after training. This may reflect a failure of either acquisition or retention. To evaluate these alternatives, rats were tested for fear-potentiated startle during fear conditioning (30 light-shock pairings [0.6 mA shock]), as well as 1-30 min and 48 hr after fear conditioning. Amygdala lesions abolished fear-potentiated startle at all train-test intervals. Intra-amygdala AP5 infusions (25 nmol/side) abolished fear-potentiated startle during the long-term test and had partial effects at shorter train-test intervals. When the level of fear-potentiated startle during the short-term test was lowered to that of the 48-hr test (i.e., by training rats with a lower, 0.3 mA footshock), AP5 abolished fear-potentiated startle at each timepoint. Thus, amygdala NMDA receptors appear to participate in the initial acquisition of fear memories.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11142635

Source DB:  PubMed          Journal:  Behav Neurosci        ISSN: 0735-7044            Impact factor:   1.912


  21 in total

1.  Consolidation of extinction learning involves transfer from NMDA-independent to NMDA-dependent memory.

Authors:  E Santini; R U Muller; G J Quirk
Journal:  J Neurosci       Date:  2001-11-15       Impact factor: 6.167

2.  Intra-amygdala blockade of the NR2B subunit of the NMDA receptor disrupts the acquisition but not the expression of fear conditioning.

Authors:  S M Rodrigues; G E Schafe; J E LeDoux
Journal:  J Neurosci       Date:  2001-09-01       Impact factor: 6.167

3.  Complex effects of NMDA receptor antagonist APV in the basolateral amygdala on acquisition of two-way avoidance reaction and long-term fear memory.

Authors:  Alena Savonenko; Tomasz Werka; Evgeni Nikolaev; Kazimierz Zieliñski; Leszek Kaczmarek
Journal:  Learn Mem       Date:  2003 Jul-Aug       Impact factor: 2.460

4.  Regulation of synaptic plasticity genes during consolidation of fear conditioning.

Authors:  Kerry J Ressler; Gayla Paschall; Xiao-liu Zhou; Michael Davis
Journal:  J Neurosci       Date:  2002-09-15       Impact factor: 6.167

5.  Distribution of NMDA and AMPA receptor subunits at thalamo-amygdaloid dendritic spines.

Authors:  Jason J Radley; Claudia R Farb; Yong He; William G M Janssen; Sarina M Rodrigues; Luke R Johnson; Patrick R Hof; Joseph E LeDoux; John H Morrison
Journal:  Brain Res       Date:  2007-01-17       Impact factor: 3.252

6.  Amygdala-dependent and amygdala-independent pathways for contextual fear conditioning.

Authors:  R Ponnusamy; A M Poulos; M S Fanselow
Journal:  Neuroscience       Date:  2007-06-22       Impact factor: 3.590

7.  Amygdala infusions of an NR2B-selective or an NR2A-preferring NMDA receptor antagonist differentially influence fear conditioning and expression in the fear-potentiated startle test.

Authors:  David L Walker; Michael Davis
Journal:  Learn Mem       Date:  2008-01-28       Impact factor: 2.460

8.  Fear memory impairing effects of systemic treatment with the NMDA NR2B subunit antagonist, Ro 25-6981, in mice: attenuation with ageing.

Authors:  Poonam Mathur; Carolyn Graybeal; Michael Feyder; Margaret I Davis; Andrew Holmes
Journal:  Pharmacol Biochem Behav       Date:  2008-09-08       Impact factor: 3.533

Review 9.  The ubiquitin-proteasome system as a critical regulator of synaptic plasticity and long-term memory formation.

Authors:  Timothy J Jarome; Fred J Helmstetter
Journal:  Neurobiol Learn Mem       Date:  2013-04-25       Impact factor: 2.877

10.  The group I metabotropic glutamate receptor mGluR5 is required for fear memory formation and long-term potentiation in the lateral amygdala.

Authors:  Sarina M Rodrigues; Elizabeth P Bauer; Claudia R Farb; Glenn E Schafe; Joseph E LeDoux
Journal:  J Neurosci       Date:  2002-06-15       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.